Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation

Yasuyuki Asai, Yutaka Makimura, Atsushi Kawabata and Tomohiko Ogawa
J Immunol December 1, 2007, 179 (11) 7674-7683; DOI: https://doi.org/10.4049/jimmunol.179.11.7674
Yasuyuki Asai
Department of Oral Microbiology, Asahi University School of Dentistry, Gifu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaka Makimura
Department of Oral Microbiology, Asahi University School of Dentistry, Gifu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Kawabata
Department of Oral Microbiology, Asahi University School of Dentistry, Gifu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiko Ogawa
Department of Oral Microbiology, Asahi University School of Dentistry, Gifu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    MS spectrum for F. nucleatum lipid A (A), and proposed chemical structures of F. nucleatum lipid A (B) and E. coli-type synthetic lipid A (compound 506) (C) (27 ).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    MS/MS spectra at m/z 1948 of F. nucleatum lipid A (A) and two corresponding proposed structural patterns (B and C).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    TLR4/MD-2-specific responsiveness to F. nucleatum lipid A. A, Peritoneal macrophages from C3H/HeN (○) and C3H/HeJ (•) mice were stimulated with the indicated doses of test specimens for 24 h in the presence of 5% FBS. After incubation, the supernatants were collected and IL-6 production was determined by ELISA. Experiments were done at least three times, with representative results presented. Each assay was done in triplicate and the data are expressed as the mean ± SD. The mean values were significantly different from medium alone. ∗, p < 0.01. B, Ba/κB, Ba/mTLR2, and Ba/mTLR4/mMD-2 cells were stimulated with 10 ng/ml of the test specimens for 4 h in the presence of 5% FBS, after which luciferase activities were measured. Results are shown as relative luciferase activity, which was determined as the ratio of stimulated to nonstimulated activity. C, Ba/κB, Ba/mTLR2, and Ba/mTLR4/mMD-2 cells were stimulated with the indicated doses of the LPL- or nontreated test specimens for 4 h in the presence of 5% FBS, after which luciferase activities were measured.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    LAL activity of F. nucleatum lipid A. The indicated doses of F. nucleatum lipid A (•) and compound 506 (○) were mixed with LAL reagent, after which LAL activity was determined using a quantitative chromogenic assay. Representative results from three independent experiments are presented.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Contribution of FBS to lipid A-induced cytokine production. Cell surface expressions of mCD14 on human monocytes (A) and HGF (D) were determined with a specific Ab (solid line) or its isotype control (dotted line), as described in Materials and Methods. Human monocytes (B and C) and HGF (E and F) were stimulated with the indicated doses of F. nucleatum lipid A (•) or compound 506 (○) for 24 h in the absence (B and E) or presence (C and F) of 5% FBS. After incubation, the supernatants were collected, and TNF-α (B and C) and IL-8 (E and F) were determined by ELISA. Each assay was done in triplicate and the data are expressed as the mean ± SD. The mean values were significantly different from F. nucleatum lipid A at each dose. ∗, p < 0.01.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Contribution of FBS to lipid A-induced up-regulation of costimulatory molecule. Murine peritoneal exudate cells were stimulated with the indicated doses of F. nucleatum lipid A (circle) or compound 506 (square) for 24 h in the absence (open symbol) or presence (closed symbol) of 5% FBS. After incubation, the cells were stained with Abs specific for CD80 and CD86, or an isotype-matched control. Values in the histograms represent the MFI of cells stained with CD80 (A) and CD86 (C), and the graph is representative of results from three experiments. Representative results for the expressions of CD80 (B) and CD86 (D) on cells stimulated with (bold line) or without (thin line) 10 ng/ml of the test specimens are shown. Dotted lines indicate cells stained with the isotype control Ab. Values indicated in the histograms represent the MFI of cells stained with each Ab.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Contribution of FBS to lipid A-induced TRIF/TICAM-1-dependent cell activation. A, IFN-β mRNA expression in murine peritoneal macrophages stimulated with the indicated doses of F. nucleatum lipid A (FnLA) or compound 506 (506) for 3 h in the absence or presence of 5% FBS. B and C, Peritoneal macrophages were stimulated with the indicated doses of FnLA (•), compound 506 (○), or Pam3CSK4 (▵) for 24 h in the absence (B) or presence (C) of 5% FBS. After incubation, the supernatants were collected and IP-10/CXCL10 production was determined by ELISA. Experiments were done at least three times, with representative results presented. Each assay was done in triplicate and the data are expressed as the mean ± SD. The mean values were significantly different from FnLA at each dose. ∗, p < 0.01.

  • FIGURE 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8.

    Contribution of sCD14 to lipid A-elicited NF-κB activation via human TLR4. Ba/hTLR4/hMD-2 cells were stimulated with the indicated doses of F. nucleatum lipid A (•) or compound 506 (○) for 4 h under the following culture conditions: medium alone (A), 1% FBS (B), 500 ng/ml CD14 (C), and 500 ng/ml CD14 together with 50 ng/ml LBP (D). NF-κB activation was measured using a luciferase assay. Results are shown as relative luciferase activity, which was determined as the ratio of stimulated to nonstimulated activity.

  • FIGURE 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 9.

    Binding of lipid A to sCD14. The indicated doses of lipid A specimens were incubated with 50 μg/ml sCD14 in the presence of 1.5 μg/ml LBP for 1 h at 37°C. Reactions were run on a 5–15% native PAGE gel. sCD14 was detected by Western blotting using a mouse anti-human CD14 Ab.

Tables

  • Figures
    • View popup
    Table I.

    Lethal toxicity of F. nucleatum lipid A and compound 506 in d-GalN-sensitized mice

    Dose of Lipid A (ng/mouse)No. of Dead Mice/Total No. of Mice Tested
    F. nucleatum lipid ACompound 506
    10/50/5
    50/52/5
    100/55/5
    503/55/5
    1005/55/5
    LD50 (ng/mouse)a48.05.7
    • a LD50, 50% lethal dose, calculated by the method of Kärber (29).

PreviousNext
Back to top

In this issue

The Journal of Immunology: 179 (11)
The Journal of Immunology
Vol. 179, Issue 11
1 Dec 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation
Yasuyuki Asai, Yutaka Makimura, Atsushi Kawabata, Tomohiko Ogawa
The Journal of Immunology December 1, 2007, 179 (11) 7674-7683; DOI: 10.4049/jimmunol.179.11.7674

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Soluble CD14 Discriminates Slight Structural Differences between Lipid As That Lead to Distinct Host Cell Activation
Yasuyuki Asai, Yutaka Makimura, Atsushi Kawabata, Tomohiko Ogawa
The Journal of Immunology December 1, 2007, 179 (11) 7674-7683; DOI: 10.4049/jimmunol.179.11.7674
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Role of the HLA Class I α2 Helix in Determining Ligand Hierarchy for the Killer Cell Ig-like Receptor 3DL1
  • Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B
  • Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function
Show more MOLECULAR AND STRUCTURAL IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606